The Clinical Practice Guidelines (CPG) for people with postpartum hemorrhage include the preventative measures during the third stage of labor, the various therapies, prognosis or prediction, diagnosis, etiology, and the perception of hemorrhage by laboring women. Compared to complementary therapy, oxytocin is the most effective treatment for postpartum hemorrhage two hours after delivery. The prognosis for postpartum hemorrhage should be executed during the early stages of pregnancy to mitigate the maternal and fetal risks of bleeding. People with placental problems such as placenta previa, placental abruption, and adherent placenta are at high risk of postpartum hemorrhage; hence oxytocin or complementary therapy should be prescribed for them (Zhang et al., 2021). Gynecologists estimate blood loss in the diagnosis of postpartum hemorrhage by assessing uterine tone and size. Urine atomy means developing a soft and weak uterus after delivery leading to the clamping of the placental blood that causes the blood vessels to shut. Oxytocin as an induction method has a higher risk for bleeding than complementary therapy.
The CPG should improve to balance the minimally invasive complementary therapy and oxytocin induction in postpartum hemorrhage management. Currently, the protocol does not provide for sufficiently appropriate diagnostic methods for the administration of alternative therapies. The guidelines should define a broader range of factors to consider when choosing between invasive complementary therapy and oxytocin induction. Thus, it is necessary to expand the possibilities for alternative options.
At the moment, the protocol can negatively impact patient outcomes, since it does not use complementary therapy often enough. This factor leads to an increased risk of bleeding with the introduction of oxytocin. Nevertheless, at present, this practice is used more often and does not take into account the characteristics of the patient, which may adversely affect the results of therapy in some particular cases.
However, laboring women perception is the biggest barrier of changing the CPG protocol. Pregnant women perceive the administration of oxytocin to be effective in making the delivery process more uncomplicated and effortless. Women have less knowledge of the risks associated with oxytocin medication, which can make appropriate therapy less effective. Contrastingly women do not believe complementary therapy has the appropriate efficacy of mitigating risks of postpartum hemorrhage.
References
Zhang, Q., Li, T., Xu, Y., & Hu, Y. (2021). The new clinical application of bilateral-contralateral cervix clamp in postpartum hemorrhage: A retrospective cohort study.BMC Pregnancy and Childbirth, 21(1), 1-6.